Hepatic Adverse Effects of Anti-Mycobacterium Tuberculosis Drugs and Their Associations with Various Genetic Variants. Precision Medicine Communications, [S. l.], v. 2, n. 1, p. 59–78, 2022. DOI: 10.55627/pmc.002.001.0053. Disponível em: https://rootspress.org/journals/index.php/PMC/article/view/53. Acesso em: 8 may. 2026.